The study of vascular biology has provided strong evidence for the role that free radical attack plays in the pathogenesis of cardiovascular diseases. The endothelial cell (EC) dysfunction that results from exposure to oxidative stresses, such as oxidized LDL, influences vascular cell gene expression, promoting smooth muscle cell (SMC) mitogenesis and apoptosis. These factors also play an important role in atherogenesis, which is attenuated by antioxidants. Thus, antioxidants are important to understanding the pathophysiology of cardiovascular diseases and to constructing an effective treatment strategy for these patients. Over the last decade, there has been a tremendous interest in the biology of heme oxygenase-1 (HO-1), which exhibits antioxidant effects in various forms of tissue injury. Moreover, the reaction is also the major source of carbon dioxide (CO) in the body, which is a physiologically important gaseous vasodilator that inhibits SMC proliferation. Thus, HO-1–derived products provide various mechanisms to maintain cardiovascular homeostasis. We review recent work on the cellular and molecular biological aspects of the HO/CO system in vascular pathophysiology.
RossRGlomsetJA. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science. 1973;180:1332–1339.
2.
JeneyVBallaJYachieA. Pro-oxidant and cytotoxic effects of circulating heme. Blood. 2002;100:879–887.
3.
MotterliniRClarkJEForestiR. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res.2002;90:E17–E24.
4.
BallaJVercellottiGMNathK. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant. 2003;18(Suppl 5):v8–v12.
5.
OhtaKYachieA. Role of heme oxygenase-1 in cardiovascular diseases: a novel target for molecular intervention?J Endovasc Ther.2001;8:444–446.
6.
ShibaharaSYoshidaTKikuchiG. Induction of heme oxygenase by hemin in cultured pig alveolar macrophages. Arch Biochem Biophys. 1978;188:243–250.
7.
MurphyBJLaderouteKRShortSM. The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer. 1991;64:69–73.
8.
EwingJFMainesMD. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc Natl Acad Sci USA. 1991;88:5364–5368.
9.
TaketaniSKohnoHYoshinagaT. Induction of heme oxygenase in rat hepatoma cells by exposure to heavy metals and hyperthermia. Biochem Int.1988;17:665–672.
10.
SiowRCIshiiTSatoH. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett.1995;368:239–242.
11.
RizzardiniMTeraoMFalcianiF. Cytokine induction of haem oxygenase mRNA in mouse liver. Interleukin 1 transcriptionally activates the haem oxygenase gene. Biochem J.1993;290:343–347.
12.
KuttyRKNagineniCNKuttyG. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol. 1994;159:371–378.
13.
McCoubreyWKHuangTJMainesMD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem. 1997;247:725–732.
14.
YachieANiidaYWadaT. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest. 1999;103:129–135.
15.
KawashimaAOdaYYachieA. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol. 2002;33:125–130.
16.
PossKDTonegawaS. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA. 1997;94:10919–10924.
17.
OhtaKYachieAFujimotoK. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis.2000;35:863–870.
18.
YangYOhtaKShimizuM. Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney Int.2003;64:1302–1309.
19.
MoritaTPerrellaMALeeME. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA. 1995;92:1475–1479.
PeytonKJReynaSVChapmanGB. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood. 2002;99:4443–4448.
22.
ToganeYMoritaTSuematsuM. Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury. Am J Physiol Heart Circ Physiol. 2000;278:H623–H632.
23.
DuranteWPeytonKJSchaferAI. Platelet-derived growth factor stimulates heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol.1999;19:2666–2672.
24.
MoritaTKourembanasS. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995;96:2676–2682.
25.
DuckersHJBoehmMTrueAL. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med.2001;7:693–698.
26.
ChauveauCBouchetDRousselJC. Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant. 2002;2:581–592.
27.
MinaminoTChristouHHsiehCM. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc Natl Acad Sci USA. 2001;98:8798–8803.
28.
PaeHOOhGSChoiBM. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol. 2004;172:4744–4751.
29.
SongRMahidharaRSZhouZ. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol. 2004;172:1220–1226.
30.
MoritaTMitsialisSAKoikeH. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem.1997;272:32804–32809.
31.
Li VoltiGWangJTraganosF. Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression. Biochem Biophys Res Commun. 2002;296:1077–1082.
32.
ZhangXBedardELPotterR. Mitogen-activated protein kinases regulate HO-1 gene transcription after ischemia-reperfusion lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;283:L815–L829.
33.
AbrahamNGKushidaTMcClungJ. Heme oxygenase-1 attenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res.2003;93:507–514.
34.
DeramaudtBMBraunsteinSRemyP. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem. 1998;68:121–127.
35.
BussolatiBAhmedAPembertonH. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood. 2004;103:761–766.
OtterbeinLEBachFHAlamJ. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med.2000;6:422–428.
41.
KushidaTLi VoltiGQuanS. Role of human heme oxygenase-1 in attenuating TNF-alpha-mediated inflammation injury in endothelial cells. J Cell Biochem. 2002;87:377–385.
42.
IshikawaKNavabMLeitingerN. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest. 1997;100:1209–1216.
43.
HayashiSTakamiyaRYamaguchiT. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res.1999;85:663–671.
44.
SoaresMPSeldonMPGregoireIP. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004;172:3553–3563.
45.
PossKDTonegawaS. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci USA. 1997;94:10925–10930.
46.
SoaresMPLinYAnratherJ. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med.1998;4:1073–1077.
47.
ZhangXShanPOtterbeinLE. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem.2003;278:1248–1258.
48.
YetSFPerrellaMALayneMD. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23–R29.
TulisDADuranteWPeytonKJ. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 2001;155:113–122.
YachieATomaTMizunoK. Heme oxygenase-1 production by peripheral blood monocytes during acute inflammatory illnesses of children. Exp Biol Med (Maywood). 2003;228:550–556.
MaruhashiKKasaharaYOhtaK. Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem. 2004;93:552.
DuranteWKrollMHChristodoulidesN. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res.1997;80:557–564.
58.
HartsfieldCLAlamJCookJL. Regulation of heme oxygenase-1 gene expression in vascular smooth muscle cells by nitric oxide. Am J Physiol. 1997;273:L980–L988.
59.
ImaiTMoritaTShindoT. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res.2001;89:55–62.
60.
WangLJLeeTSLeeFY. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol. 1998;152:711–720.
OtterbeinLEZuckerbraunBSHagaM. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med.2003;9:183–190.
65.
YamashitaKMcDaidJOllingerR. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J.2004;18:765–767.
66.
PhilippidisPMasonJCEvansBJ. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res.2004;94:119–126.
67.
ExnerMSchillingerMMinarE. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J Endovasc Ther.2001;8:433–440.
68.
ChenYHChauLYLinMW. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting. Eur Heart J.2004;25:39–47.
69.
SchillingerMExnerMMinarE. Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor. JAm Coll Cardiol. 2004;43:950–957.
70.
KanedaHOhnoMTaguchiJ. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol.2002;22:1680–1685.
71.
OnoKGotoYTakagiS. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis. 2004;173:315–319.
72.
EndlerGExnerMSchillingerM. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost. 2004;91:155–161.
73.
HiraiHKuboHYamayaM. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood. 2003;102:1619–1621.
74.
VisnerGALuFZhouH. Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation. 2003;107:911–916.
75.
LeeTSChauLY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med.2002;8:240–246.
76.
TangYLTangYZhangYC. Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension. 2004;43:746–751.
